The Advanced ZAP-X Gyroscopic Radiosurgery Platform to The Institut du Cancer Courlancy
Site to be Among Europe’s First to Offer Groundbreaking Innovation in Non-Invasive Treatment for Brain Tumors
SAN CARLOS, Calif.–(BUSINESS WIRE)–ZAP Surgical Systems, Inc. today announced that the Institut du Cancer Courlancy (ICC) in Reims, France will add the latest advancement in non-invasive brain tumor treatments, the ZAP-X® Gyroscopic Radiosurgery® platform, to its current portfolio of cancer treatment technologies.
ZAP-X® Gyroscopic Radiosurgery Platform® (Graphic: Business Wire)
